Venator Announces Fourth Quarter and Full-Year 2021 Results: Strong Improvement in Selling Prices Mitigates Cost Pressures
Venator Materials PLC (VNTR) reported a fourth quarter 2021 net income of $14 million, recovering from a net loss of $58 million a year earlier. Adjusted EBITDA rose to $40 million from $25 million. However, free cash flow was negative at $(9) million. Revenue for Q4 was $535 million, an increase of 12% year-over-year. For the full year, the net loss was $77 million compared to $112 million in 2020. Average TiO2 selling prices increased by 20% in Q4, although sales volumes fell by 2%. Venator also implemented cost-saving measures expected to save over $20 million annually.
- Net income of $14 million in Q4 2021, a significant recovery from a $58 million loss in Q4 2020.
- Adjusted EBITDA rose to $40 million from $25 million year-over-year.
- Revenue increased by 12% year-over-year to $535 million in Q4 2021.
- Achieved $14 million in adjusted EBITDA improvements from business programs.
- Expected future annual cash savings exceeding $20 million from pension plan revaluation.
- Free cash flow was negative at $(9) million for Q4 2021.
- Sales volumes decreased by 2% in the TiO2 segment, indicating possible demand challenges.
- Full-year net loss of $77 million, although improved from the previous year's loss.
WYNYARD, UK, Feb. 22, 2022 /PRNewswire/ --
Fourth Quarter 2021 Highlights
- Net income attributable to Venator of
$14 million compared to net loss of$58 million in the prior year period - Adjusted EBITDA of
$40 million compared to$25 million in the prior year period - Net cash provided by operating activities was
$17 million and free cash flow was$(9) million - Diluted income per share of
$0.13 and adjusted diluted loss per share of$0.05 - Compared to the third quarter of 2021, TiO2 average selling prices increased
6% in local currency and TiO2 sales volumes were10% lower, primarily due to seasonality
Full-Year 2021 Highlights
- Net loss attributable to Venator of
$77 million compared to$112 million in the prior year - Adjusted EBITDA of
$180 million compared to$136 million in the prior year - Net cash provided by operating activities of
$19 million and free cash flow of$(54) million - Diluted loss per share of
$0.72 and adjusted diluted loss per share of$(0.01) - Completed valuation of largest pension plan, expect more than
$20 million in future annual cash savings - Delivered an incremental
$14 million of adjusted EBITDA improvements as part of our business improvement programs in 2021
Three months ended | Twelve months ended | |||||||||
December 31, | September 30, | December 31, | ||||||||
(In millions, except per share amounts) | 2021 | 2020 | 2021 | 2021 | 2020 | |||||
Revenues | $ 535 | $ 476 | $ 557 | $ 2,212 | $ 1,938 | |||||
Net income (loss) attributable to Venator | $ 14 | $ (58) | $ (47) | $ (77) | $ (112) | |||||
Adjusted net (loss) income(2) | $ (5) | $ (13) | $ 3 | $ (1) | $ (22) | |||||
Adjusted EBITDA(1) | $ 40 | $ 25 | $ 48 | $ 180 | $ 136 | |||||
Diluted income (loss) per share | $ 0.13 | $ (0.54) | $ (0.44) | $ (0.72) | $ (1.05) | |||||
Adjusted diluted (loss) earnings per share(1). (4) | $ (0.05) | $ (0.12) | $ 0.03 | $ (0.01) | $ (0.21) | |||||
Net cash provided by operating activities | $ 17 | $ 34 | $ 7 | $ 19 | $ 34 | |||||
Free cash flow(3) | $ (9) | $ 19 | $ (13) | $ (54) | $ (35) | |||||
Venator Materials PLC ("Venator") (NYSE: VNTR) today reported fourth quarter 2021 results with revenues of
Simon Turner, President and CEO of Venator, commented:
"In 2021 demand recovered and remained strong throughout the year. Notwithstanding pressure on our supply chains, sales volumes increased
"In 2021, we continued to make structural improvements to our cash uses, including a revaluation of our largest pension plan from which we expect more than
"We are increasing production to meet the requirements of our customers for all our products throughout 2022. We continue to increase our selling prices to align with the inflationary cost environment. TiO2 fundamentals remain intact and we are committed to expanding our margins and improving our cash flow profile."
Segment Analysis for 4Q21 Compared to 4Q20
Titanium Dioxide
The Titanium Dioxide segment generated revenues of
Adjusted EBITDA for the Titanium Dioxide segment was
Performance Additives
The Performance Additives segment generated revenues of
Adjusted EBITDA for the Performance Additives segment was
Corporate and Other
Corporate and other represents expenses which are not allocated to our segments. Losses from Corporate and other were
Tax Items
We recorded an income tax benefit of
Our income taxes are significantly affected by the mix of income and losses in tax jurisdictions and valuation allowances in certain jurisdictions in which we operate. In 2022, we expect to see an adjusted effective tax rate of approximately
Liquidity and Capital Resources
As of December 31, 2021, we had cash and cash equivalents of
Capital expenditures totaled
Earnings Conference Call Information
We will hold a conference call to discuss our fourth quarter and full-year 2021 results on, Tuesday February 22, 2022, at 08:00 a.m. ET.
Call-in numbers for the conference call: | |
U.S. participants | 1-833-366-1118 |
International participants | 1-412-902-6770 |
(No passcode required) |
In order to facilitate the registration process, you may use the following link to pre-register for the conference call. Callers who pre-register will be given a unique PIN and separate call-in number to gain immediate access to the call and bypass the live operator. To pre-register, please go to:
https://dpregister.com/sreg/10163189/f0d3f802e6
Webcast Information
The conference call will be available via webcast and can be accessed from the company's website at venatorcorp.com/investor-relations.
Replay Information
The conference call will be available for replay beginning February 22, 2022 and ending March 1, 2022.
Call-in numbers for the replay: | |
U.S. participants | 1-877-344-7529 |
International participants | 1-412-317-0088 |
Passcode | 9937974 |
Upcoming Conferences
During the first quarter of 2022, a member of management is expected to present at the J.P. Morgan Global High Yield & Leveraged Finance Conference on March 1 and at the Bank of America Merrill Lynch Global Agriculture and Materials Conference on March 2. A webcast of the presentations, if applicable, along with accompanying materials will be available at venatorcorp.com/investor-relations.
Table 1 — Results of Operations | ||||||||
Three months ended | Twelve months ended | |||||||
December 31, | December 31, | |||||||
(In millions, except per share amounts) | 2021 | 2020 | 2021 | 2020 | ||||
Revenues | $ 535 | $ 476 | $ 2,212 | $ 1,938 | ||||
Cost of goods sold | 491 | 442 | 2,020 | 1,778 | ||||
Operating expenses | 53 | 49 | 182 | 170 | ||||
Restructuring, impairment, and plant closing and transition costs | 8 | 33 | 68 | 58 | ||||
Operating loss | (17) | (48) | (58) | (68) | ||||
Interest expense, net | (15) | (15) | (59) | (52) | ||||
Other income | 2 | 15 | 12 | 27 | ||||
Loss before income taxes | (30) | (48) | (105) | (93) | ||||
Income tax benefit (expense) | 45 | (9) | 31 | (12) | ||||
Net income (loss) | 15 | (57) | (74) | (105) | ||||
Net income attributable to noncontrolling interests | (1) | (1) | (3) | (7) | ||||
Net income (loss) attributable to Venator | $ 14 | $ (58) | $ (77) | $ (112) | ||||
Adjusted EBITDA(1) | $ 40 | $ 25 | $ 180 | $ 136 | ||||
Adjusted net loss(1) | $ (5) | $ (13) | $ (1) | $ (22) | ||||
Basic & diluted earnings (loss) per share | $ 0.13 | $ (0.54) | $ (0.72) | $ (1.05) | ||||
Adjusted basic & diluted loss per share(1,4) | $ (0.05) | $ (0.12) | $ (0.01) | $ (0.21) | ||||
Ordinary share information: | ||||||||
Basic shares outstanding | 107.3 | 106.7 | 107.2 | 106.7 | ||||
Diluted shares outstanding | 107.7 | 106.7 | 107.2 | 106.7 | ||||
See end of press release for footnote explanations |
Table 2 — Results of Operations by Segment | ||||||||||||
Three months ended | Twelve months ended | |||||||||||
December 31, | Better / | December 31, | Better / | |||||||||
(In millions) | 2021 | 2020 | (Worse) | 2021 | 2020 | (Worse) | ||||||
Segment Revenues: | ||||||||||||
Titanium Dioxide | $ 406 | $ 348 | $ 1,665 | $ 1,431 | ||||||||
Performance Additives | 129 | 128 | 547 | 507 | ||||||||
Total | $ 535 | $ 476 | $ 2,212 | $ 1,938 | ||||||||
Segment Adjusted EBITDA(1): | ||||||||||||
Titanium Dioxide | $ 35 | $ 25 | $ 165 | $ 127 | ||||||||
Performance Additives | 19 | 15 | 65 | 55 | ||||||||
Corporate and other | (14) | (15) | (50) | (46) | (9)% | |||||||
Total | $ 40 | $ 25 | $ 180 | $ 136 | ||||||||
See end of press release for footnote explanations |
Table 3 — Factors Impacting Sales Revenue | |||||||||||
Three months ended | |||||||||||
December 31, 2021 vs. 2020 | |||||||||||
Average Selling Price(a) | |||||||||||
Local | Exchange | Sales Mix | Sales | Divestitures | Total | ||||||
Titanium Dioxide | (1)% | —% | (2)% | —% | |||||||
Performance Additives | —% | —% | (2)% | (5)% | |||||||
Total Company | (1)% | —% | (2)% | (2)% | |||||||
Twelve months ended | |||||||||||
December 31, 2021 vs. 2020 | |||||||||||
Average Selling Price(a) | |||||||||||
Local | Exchange | Sales Mix | Sales | Divestitures | Total | ||||||
Titanium Dioxide | —% | —% | |||||||||
Performance Additives | (3)% | ||||||||||
Total Company | —% | (1)% | |||||||||
(a) | Excludes revenues from tolling arrangements, by-products and raw materials |
(b) | Excludes sales volumes of by-products and raw materials |
(c) | Our water treatment business was disposed of in the second quarter of 2021 |
Table 4 — Reconciliation of U.S. GAAP to Non-GAAP Measures | ||||||||||||
EBITDA | Net Income | Diluted Earnings | ||||||||||
Three months | Three months | Three months | ||||||||||
December 31, | December 31, | December 31, | ||||||||||
(In millions, except per share amounts) | 2021 | 2020 | 2021 | 2020 | 2021 | 2020 | ||||||
Net income (loss) | $ 15 | $ (57) | ||||||||||
Net income attributable to noncontrolling interests | (1) | (1) | (1) | (1) | (0.01) | (0.01) | ||||||
Net income (loss) attributable to Venator | 14 | (58) | 14 | (58) | 0.13 | (0.54) | ||||||
Interest expense, net | 15 | 15 | ||||||||||
Income tax (benefit) expense | (45) | 9 | ||||||||||
Depreciation and amortization | 30 | 29 | ||||||||||
Business acquisition and integration credits | 1 | — | 1 | — | 0.01 | — | ||||||
Separation gain | 3 | (10) | 3 | (10) | 0.03 | (0.09) | ||||||
Loss/(gain) on disposition of businesses/assets | 7 | (1) | 7 | (1) | 0.07 | (0.01) | ||||||
Certain legal expenses/settlements | 1 | 3 | 1 | 3 | 0.01 | 0.03 | ||||||
Amortization of pension and postretirement actuarial losses | 2 | 3 | 2 | 3 | 0.02 | 0.03 | ||||||
Net plant incident costs | 4 | 2 | 4 | 2 | 0.04 | 0.02 | ||||||
Restructuring, impairment, plant closing and transition costs | 8 | 33 | 8 | 33 | 0.07 | 0.31 | ||||||
Income tax adjustments(2) | — | — | (45) | 15 | (0.42) | 0.14 | ||||||
Adjusted(1) | $ 40 | $ 25 | $ (5) | |||||||||
Adjusted income tax expense(2) | $ — | $ (6) | ||||||||||
Net income attributable to noncontrolling interests, net of tax | 1 | 1 | ||||||||||
Adjusted pre-tax loss(1) | $ (4) | |||||||||||
Adjusted effective tax rate | ||||||||||||
EBITDA | Net Income | Diluted Earnings | ||||||||||
Three months | Three months | Three months | ||||||||||
September 30, | September 30, | September 30, | ||||||||||
(In millions, except per share amounts) | 2021 | 2021 | 2021 | |||||||||
Net loss | $ (47) | $ (47) | $ (0.44) | |||||||||
Net income attributable to noncontrolling interests | — | — | — | |||||||||
Net loss attributable to Venator | (47) | (47) | (0.44) | |||||||||
Interest expense, net | 15 | |||||||||||
Income tax expense | 4 | |||||||||||
Depreciation and amortization | 29 | |||||||||||
Certain legal expenses/settlements | 3 | 3 | 0.03 | |||||||||
Amortization of pension and postretirement actuarial losses | 3 | 3 | 0.03 | |||||||||
Net plant incident costs | 6 | 6 | 0.06 | |||||||||
Restructuring, impairment, plant closing and transition costs | 35 | 35 | 0.33 | |||||||||
Income tax adjustments(2) | — | 3 | 0.03 | |||||||||
Adjusted(1) | $ 48 | $ 3 | $ 0.03 | |||||||||
Adjusted income tax expense(2) | $ 1 | |||||||||||
Net income attributable to noncontrolling interests, net of tax | — | |||||||||||
Adjusted pre-tax income(1) | $ 4 | |||||||||||
Adjusted effective tax rate | ||||||||||||
EBITDA | Net Income | Diluted Earnings | ||||||||||
Twelve months | Twelve months ended | Twelve months ended | ||||||||||
December 31, | December 31, | December 31, | ||||||||||
(In millions, except per share amounts) | 2021 | 2020 | 2021 | 2020 | 2021 | 2020 | ||||||
Net loss | $ (74) | |||||||||||
Net income attributable to noncontrolling interests | (3) | (7) | (3) | (7) | (0.03) | (0.07) | ||||||
Net loss attributable to Venator | (77) | (112) | (77) | (112) | (0.72) | (1.05) | ||||||
Interest expense, net | 59 | 52 | ||||||||||
Income tax (benefit) expense | (31) | 12 | ||||||||||
Depreciation and amortization | 119 | 114 | ||||||||||
Business acquisition and integration expenses | 1 | 1 | 1 | 1 | 0.01 | 0.01 | ||||||
Separation loss (gain) | 3 | (10) | 3 | (10) | 0.03 | (0.09) | ||||||
Loss (gain) on disposition of businesses/assets | 9 | (5) | 9 | (5) | 0.08 | (0.05) | ||||||
Certain legal expenses/settlements | 5 | 6 | 5 | 6 | 0.05 | 0.06 | ||||||
Amortization of pension and postretirement actuarial losses | 11 | 13 | 11 | 13 | 0.10 | 0.12 | ||||||
Net plant incident costs | 13 | 7 | 13 | 7 | 0.12 | 0.07 | ||||||
Restructuring, impairment, plant closing and transition costs | 68 | 58 | 68 | 58 | 0.63 | 0.54 | ||||||
Income tax adjustments(2) | — | — | (34) | 20 | (0.32) | 0.19 | ||||||
Adjusted(1) | $ 180 | $ 136 | $ (1) | |||||||||
Adjusted income tax benefit (expense)(2) | $ 3 | $ (8) | ||||||||||
Net income attributable to noncontrolling interests, net of tax | 3 | 7 | ||||||||||
Adjusted pre-tax income (loss)(1) | $ 5 | |||||||||||
Adjusted effective tax rate | ||||||||||||
See end of press release for footnote explanations |
Table 5 — Selected Balance Sheet Items | ||||||
December 31, | September 30, | December 31, | ||||
(In millions) | 2021 | 2021 | 2020 | |||
Cash | $ 156 | $ 161 | $ 220 | |||
Accounts and notes receivable, net | 371 | 394 | 324 | |||
Inventories | 478 | 418 | 440 | |||
Prepaid and other current assets | 84 | 80 | 73 | |||
Property, plant and equipment, net | 848 | 869 | 947 | |||
Other assets | 427 | 380 | 353 | |||
Total assets | $ 2,364 | $ 2,302 | $ 2,357 | |||
Accounts payable | $ 377 | $ 319 | $ 262 | |||
Other current liabilities | 131 | 127 | 126 | |||
Current portion of debt | 5 | 5 | 7 | |||
Long-term debt | 949 | 949 | 950 | |||
Non-current payable to affiliates | 21 | 17 | 17 | |||
Other liabilities | 313 | 364 | 371 | |||
Total equity | 568 | 521 | 624 | |||
Total liabilities and equity | $ 2,364 | $ 2,302 | $ 2,357 | |||
Table 6 — Outstanding Debt | ||||||
December 31, | September 30, | December 31, | ||||
(In millions) | 2021 | 2021 | 2020 | |||
Debt: | ||||||
Term Loan Facility | $ 356 | $ 357 | $ 359 | |||
Senior Secured Notes | 217 | 216 | 215 | |||
Senior Unsecured Notes | 372 | 372 | 372 | |||
Other debt | 9 | 9 | 11 | |||
Total debt - excluding affiliates | $ 954 | $ 954 | $ 957 | |||
Total cash | 156 | 161 | 220 | |||
Net debt - excluding affiliates (5) | $ 798 | $ 793 | $ 737 | |||
Table 7 — Summarized Statement of Cash Flows | ||||||||
Three months ended | Twelve months ended | |||||||
December 31, | December 31, | |||||||
(In millions) | 2021 | 2020 | 2021 | 2020 | ||||
Total cash at beginning of period | $ 161 | $ 208 | $ 220 | $ 55 | ||||
Net cash provided by operating activities | 17 | 34 | 19 | 34 | ||||
Net cash used in investing activities | (13) | (21) | (60) | (64) | ||||
Net cash (used in) provided by financing activities | (9) | (3) | (21) | 192 | ||||
Effect of exchange rate changes on cash | — | 2 | (2) | 3 | ||||
Total cash at end of period | $ 156 | $ 220 | $ 156 | $ 220 | ||||
Supplemental cash flow information: | ||||||||
Cash paid for interest | $ (4) | $ (4) | $ (62) | $ (39) | ||||
Cash paid for income taxes | (9) | (3) | (14) | (3) | ||||
Capital expenditures | (26) | (15) | (73) | (69) | ||||
Depreciation and amortization | 30 | 29 | 119 | 114 | ||||
Restructuring | (4) | (3) | (11) | (10) | ||||
Net cash flows associated with Pori | (2) | (5) | (12) | (8) | ||||
Changes in primary working capital: | ||||||||
Accounts and notes receivable | 14 | (6) | (65) | 14 | ||||
Inventories | (68) | 15 | (60) | 102 | ||||
Accounts payable | 56 | 36 | 120 | (77) | ||||
Total cash provided by (used in) primary working capital | $ 2 | $ 45 | $ (5) | $ 39 | ||||
Three months ended | Twelve months ended | |||||||
December 31, | December 31, | |||||||
(In millions) | 2021 | 2020 | 2021 | 2020 | ||||
Free cash flow(3): | ||||||||
Net cash provided by operating activities | $ 17 | $ 34 | $ 19 | $ 34 | ||||
Capital expenditures | (26) | (15) | (73) | (69) | ||||
Total free cash flow(3) | $ (9) | $ 19 | $ (54) | $ (35) | ||||
See end of press release for numbered footnote explanations |
Footnotes | |
(1) | Our management uses adjusted EBITDA to assess financial performance. Adjusted EBITDA is defined as net income/loss before interest income/expense, net, income tax expense/benefit, depreciation and amortization, and net income attributable to noncontrolling interests, as well as eliminating the following adjustments: (a) business acquisition and integration expense/credits; (b) separation gain/expense; (c) loss/gain on disposition of businesses/assets; (d) certain legal expenses/settlements; (e) amortization of pension and postretirement actuarial losses/gains; (f) net plant incident costs/credits; and (g) restructuring, impairment, and plant closing and transition costs/credits. We believe that net income is the performance measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to adjusted EBITDA. |
We believe adjusted EBITDA is useful to investors in assessing our ongoing financial performance and provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of our operational profitability and that may obscure underlying business results and trends. However, this measure should not be considered in isolation or viewed as a substitute for net income or other measures of performance determined in accordance with U.S. GAAP. Moreover, adjusted EBITDA as used herein is not necessarily comparable to other similarly titled measures of other companies due to potential inconsistencies in the methods of calculation. Our management believes this measure is useful to compare general operating performance from period to period and to make certain related management decisions. Adjusted EBITDA is also used by securities analysts, lenders and others in their evaluation of different companies because it excludes certain items that can vary widely across different industries or among companies within the same industry. For example, interest expense can be highly dependent on a company's capital structure, debt levels and credit ratings. Therefore, the impact of interest expense on earnings can vary significantly among companies. In addition, the tax positions of companies can vary because of their differing abilities to take advantage of tax benefits and because of the tax policies of the various jurisdictions in which they operate. As a result, effective tax rates and tax expense can vary considerably among companies. Finally, companies employ productive assets of different ages and utilize different methods of acquiring and depreciating such assets. This can result in considerable variability in the relative costs of productive assets and the depreciation and amortization expense among companies. | |
Nevertheless, our management recognizes that there are limitations associated with the use of adjusted EBITDA in the evaluation of us as compared to net income. Our management compensates for the limitations of using adjusted EBITDA by using this measure to supplement U.S. GAAP results to provide a more complete understanding of the factors and trends affecting the business rather than U.S. GAAP results alone. | |
In addition to the limitations noted above, adjusted EBITDA excludes items that may be recurring in nature and should not be disregarded in the evaluation of performance. However, we believe it is useful to exclude such items to provide a supplemental analysis of current results and trends compared to other periods because certain excluded items can vary significantly depending on specific underlying transactions or events, and the variability of such items may not relate specifically to ongoing operating results or trends and certain excluded items, while potentially recurring in future periods, may not be indicative of future results. | |
Adjusted net income (loss) attributable to Venator Materials PLC ordinary shareholders is computed by eliminating the after-tax amounts related to the following from net income/loss attributable to Venator Materials PLC ordinary shareholders: (a) business acquisition and integration expenses/adjustments; (b) loss/gain on disposition of businesses/assets; (c) certain legal expenses/settlements; (d) amortization of pension and postretirement actuarial losses/gains; (e) net plant incident costs/credits; and (f) restructuring, impairment, and plant closing and transition costs/credits. Basic adjusted net income per share excludes dilution and is computed by dividing adjusted net income by the weighted average number of shares outstanding during the period. Adjusted diluted net income per share reflects all potential dilutive ordinary shares outstanding during the period increased by the number of additional shares that would have been outstanding as dilutive securities. | |
Adjusted net income (loss) and adjusted net earnings (loss) per share amounts are presented solely as supplemental information. These measures exclude similar noncash items as Adjusted EBITDA in order to assist our investors in comparing our performance from period to period and as such, bear similar risks as Adjusted EBITDA as documented above. For that reason, adjusted net income and the related per share amounts, should not be considered in isolation and should be considered only to supplement analysis of U.S. GAAP results. | |
(2) | Income tax expense is adjusted by the amount of additional tax expense or benefit that we would accrue if we used non-GAAP results instead of GAAP results in the calculation of our tax liability, taking into consideration our tax structure. We use a normalized effective tax rate of |
We eliminate the effect of significant changes to income tax valuation allowances from our presentation of adjusted net income to allow investors to better compare our ongoing financial performance from period to period. We do not adjust for insignificant changes in tax valuation allowances because we do not believe it provides more meaningful information than is provided under GAAP. We believe that our revised approach enables a clearer understanding of the long-term impact of our tax structure on post tax earnings. | |
(3) | Management internally uses a free cash flow measure: (a) to evaluate the Company's liquidity, (b) to evaluate strategic investments, (c) to evaluate the Company's ability to incur and service debt. Free cash flow is not a defined term under U.S. GAAP, and it should not be inferred that the entire free cash flow amount is available for discretionary expenditures. Free cash flow is defined as cash flows provided by (used in) operating activities from continuing operations less capital expenditures. The company updated its definition of free cash flow during the third quarter of 2021 to conform to the definition more commonly used by publicly traded companies. Prior to the third quarter of 2021, free cash flow was defined as cash flows provided by (used in) operating activities from continuing operations and used in investing activities. Prior period comparatives within this release have been restated for the updated definition. Free cash flow is typically derived directly from the Company's consolidated statement of cash flows; however, it may be adjusted for items that affect comparability between periods. Free cash flow is presented as supplemental information. |
(4) | The potentially dilutive impact of share-based awards was excluded from the calculation of earnings per share for the twelve months ended December 31, 2021 because there is an anti-dilutive effect as we are in a net loss position. |
(5) | "Net debt" is not a defined term under U.S. GAAP. We define net debt as debt (the most comparable GAAP measure, calculated as long-term obligations plus short-term borrowings) minus cash and cash equivalents. Management believes that net debt is an important measure to monitor leverage and evaluate the balance sheet. |
About Venator
Venator is a global manufacturer and marketer of chemical products that comprise a broad range of pigments and additives that bring color and vibrancy to buildings, protect and extend product life, and reduce energy consumption. We market our products globally to a diversified group of industrial customers through two segments: Titanium Dioxide, which consists of our TiO2 business, and Performance Additives, which consists of our functional additives, color pigments and timber treatment businesses. Based in Wynyard, U.K., Venator employs approximately 3,500 associates and sells its products in more than 110 countries.
Social Media:
Twitter: www.twitter.com/VenatorCorp
Facebook: www.facebook.com/venatorcorp
LinkedIn: www.linkedin.com/company/venator-corp
Cautionary Statement Concerning Forward-Looking Statements
Certain statements contained in this press release constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These forward- looking statements represent Venator's expectations or beliefs concerning future events, and it is possible that the expected results described in this press release will not be achieved. These forward looking statements are subject to risks, uncertainties and other factors, many of which are outside of Venator's control, that could cause actual results to differ materially from the results discussed in the forward looking statements, including the impacts and duration of the global outbreak of the COVID-19 pandemic on the global economy and all aspects of our business, including our employees, customers, suppliers, partners, results of operations, financial condition and liquidity, global economic conditions, our ability to maintain sufficient working capital, our ability to access capital markets on favorable terms, the costs associated with the closure of our Pori facility and execution of our business improvement programs and initiatives, our ability to realize financial and operational benefits from our business improvement plans and initiatives, changes in raw material and energy prices, interruptions in raw materials and energy, industry production capacity and operating rates, the supply demand balance for our products and that of competing products, pricing pressures, technological developments, legal claims by or against us, changes in government regulations, including increased manufacturing, labeling and waste disposal regulations and the classification of TiO2 as a carcinogen in the EU, management of materials resulting from our manufacturing process, including the ability to develop commercial markets in the regions that we manufacture and out ability to dispose of these materials if necessary, the impacts of increasing climate change regulations, geopolitical events, cyberattacks and public health crises.
Any forward-looking statement speaks only as of the date on which it is made, and, except as required by law, Venator does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for Venator to predict all such factors. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements in Venator's Annual Report on Form 20-F for the year ended December 31, 2021 filed with the SEC. The risk factors and other factors noted therein could cause its actual results to differ materially from those contained in any forward-looking statement.
View original content to download multimedia:https://www.prnewswire.com/news-releases/venator-announces-fourth-quarter-and-full-year-2021-results-strong-improvement-in-selling-prices-mitigates-cost-pressures-301487274.html
SOURCE Venator Materials PLC
FAQ
What were Venator's financial results for Q4 2021?
How did Venator's adjusted EBITDA perform in Q4 2021?
What is the TiO2 sales volume trend for Venator in Q4 2021?
What is Venator's outlook on cost savings from pension plan changes?
What was Venator's free cash flow in Q4 2021?
